ArticleGeroScience2026
Intestinal oxysterol remodeling underlies severe COVID-19 in an aged hamster model.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Age is a critical determinant of COVID-19 severity, yet the underlying metabolic mechanisms driving disease progression remain poorly understood. Using a well-characterized Syrian hamster model, we investigated how aging shapes intestinal and systemic sterol metabolism during SARS-CoV-2 infection. Young (7-10 weeks) and aged (12 months) hamsters were intranasally infected, and clinical outcomes were integrated with virological, histopathological, and lipidomic profiles across intestinal tissues, lungs, and serum. Despite comparable pulmonary pathology, aged hamsters exhibited significantly higher intestinal viral loads and more pronounced clinical decline than young counterparts. We identified a clear age-dependent divergence in sterol responses: young hamsters mounted a robust systemic induction of antiviral side-chain oxysterols, notably 25-hydroxycholesterol (25-HC) and 27-hydroxycholesterol (27-HC), in both intestinal tissues and serum. In contrast, this protective response was markedly blunted in aged animals. Moreover, aged hosts displayed a selective accumulation of ring oxysterols, particularly colonic 4β-hydroxycholesterol (4β-HC), which correlated positively with viral burden and clinical severity. Correlation analyses revealed a functional intestinal-systemic axis, where gut-derived and circulating side-chain oxysterols were inversely associated with lung cholesterol levels and clinical scores. These findings suggest that youthful metabolic responses may limit viral spread and disease progression by reducing cellular entry through modulation of pulmonary cholesterol homeostasis, while oxysterols may additionally exert direct antiviral effects-a defense mechanism that diminishes with advancing age. Collectively, these findings identify the intestine as a potential contributor to the systemic metabolic alterations associated with age-dependent COVID-19 severity and suggest oxysterol pathways as promising candidates for future mechanistic investigations and therapeutic exploration.
Indexed as
Identifiers
42776388What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.